Pédiatrie Tumeurs solides
LYNPARZA (D0816C000025)
A Phase I, Open-label, Parallel Group Study to Investigate Olaparib Safety;and Tolerability, Efficacy and Pharmacokinetics in Paediatric Patients with;Solid Tumours
Paris
ISABELLE AERTS